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BOLD-MRI (blood oxygenation-level dependent magnetic resonance imaging) allows
non-invasive measurement of renal tissue oxygenation in humans, without the need for
contrast products. BOLD-MRI uses the fact that magnetic properties of hemoglobin
depend of its oxygenated state:: the higher local deoxyhemoglobin, the higher the so
called apparent relaxation rate R2∗ (sec−1), and the lower local tissue oxygen content.
Several factors other than deoxyhemoglobin (such as hydration status, dietary sodium
intake, and susceptibility effects) influence the BOLD signal, and need to be taken
into account when interpreting results. The last 5 years have witnessed important
improvements in the standardization of these factors, and the appearance of new,
highly reproducible analysis techniques of BOLD-images, that are reviewed in this article.
Using these new BOLD-MRI analysis techniques, it has recently been shown that
persons suffering from chronic kidney diseases (CKD) have lower cortical oxygenation
than normotensive controls, thus confirming the chronic hypoxia hypothesis. The acute
alterations in R2∗ after the administration of furosemide are smaller in CKD, and represent
an estimate of the oxygen-dependent tubular transport of sodium. BOLD-MRI-alone or
in combination with other functional MRI methods- can be used to monitor the renal
effects of drugs, and is increasingly used in the preclinical setting. The near future will
tell whether or not BOLD-MRI represents a new tool to predict renal function decline an
adverse renal outcome.
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INTRODUCTION
Chronic kidney disease (CKD), defined as an estimated glomerular filtration rate below 60
ml/min/1.73 m2 and/or the presence of (micro) albuminuria, has become a major public health
problem with a global prevalence in the general population of ∼10% (Ponte et al., 2013). CKD
is an independent cardiovascular risk factor and associated with increased mortality (Astor et al.,
2011). The pathophysiology of CKD and its progression to end stage renal disease is complex and
incompletely understood, but mounting evidence from animal studies suggests that renal tissue
hypoxia is the final and common pathway, irrespective of etiology (Alberti and Zimmet, 1998; Fine
and Norman, 2008). According to this “chronic hypoxia hypothesis,” loss of peritubular capillaries
induces interstitial hypoxia which triggers local inflammation and fibrosis. This leads in turn to
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further obliteration and loss of capillaries, thus completing the
vicious circle. So far, evidence for the chronic hypoxia hypothesis
in humans has been sparse, mainly because of the lack of methods
to assess renal tissue oxygenation in a reliable, non-invasive
manner.
A technique to measure tissue oxygenation in humans would
be a valuable tool for several reasons. First of all, such a
technique could be used to confirm or reject the chronic hypoxia
hypothesis. Secondly, ideally it would allow to identify CKD
patients at increased risk for rapid renal function decline and
end-stage renal disease, since according to the chronic hypoxia
hypothesis, those with the lowest degree of oxygenation have
the highest renal risk. Finally, drugs that chronically increase
renal tissue oxygenation would have the potential to retard the
progression of CKD. Thus, a method capable of measuring renal
tissue oxygenation could identify at an early stage drugs with
oxygen-increasing and possibly nephroprotective potential.
Since its first description in 1996 (Prasad et al., 1996),
renal blood oxygenation-level dependent MRI (BOLD-MRI) is
seen by many as the most promising method to assess renal
oxygenation non-invasively in humans. In brief, BOLD-MRI uses
the paramagnetic properties of deoxyhemoglobin to assess tissue
oxygenation: the higher local deoxyhemoglobin, the higher the
apparent relaxation rate R2∗ (sec−1), and the lower local tissue
oxygen content, assuming that blood pO2 is in equilibrium with
tissue pO2. BOLD-MRI does not require the administration of
(possibly nephrotoxic) contrast media, making it an interesting
tool for CKD patients. BOLD-MRI is fast and can be repeated
many times in short time intervals without side-effects.
Despite these advantages, BOLD-MRI is for the moment
mainly used in research settings and not yet fully integrated in
clinical practice. The initial enthusiasm was tempered by studies
who failed to demonstrate with BOLD-MRI that chronic hypoxia
is indeed present in humans. Besides, we have learned that
factors other than oxygenation (such as blood pH, hematocrite,
hydration status, and susceptibility effects, see below) influence
the BOLD-signal (Prasad and Epstein, 1999; Pruijm et al., 2010;
Neugarten, 2012). However, progress has been made in the
standardization of these factors, as well as in data acquisition and
analysis, which has recently lead to interesting results and will
possibly lead to new applications for this technique. In this article,
we review the technical hurdles that had to be overcome, others
that still need to be resolved, the main results of clinical studies
and the perspectives of BOLD-MRI.
BOLD-MRI: TECHNIQUE AND PITFALLS
The basic principle of Magnetic Resonance Imaging (MRI) can
be summarized as follows: when atomic nuclei with non-zero
angular momentum (like hydrogen) are placed in a magnetic
field and reach thermal equilibrium, an excess of nuclei lying
in the low energy state appears. This excess of nuclei can
be brought to some higher energy state when excited by an
electromagnetic wave (pulse). The nuclei return to equilibrium
after the excitation while emitting back a radiation; this takes
a certain time, measured as the so called relaxation times (T1
and T2). These parameters provide information about the density
and localization of (hydrogen or other) nuclei, and allow the
construction of an image.
BOLD-MRI measures the apparent relaxation rate R2∗ (or
decay rate, defined as 1/T2∗ and expressed in sec−1) for
each voxel located in the kidney. This parameter is influenced
by any kind of inhomogeneity in the static magnetic field,
in particular by the effect of deoxyhemoglobin, which has a
strong positive magnetic susceptibility due to its central iron
atom. The susceptibility difference between deoxyhemoglobin
and surrounding tissues will generate intra-voxel magnetic field
inhomogeneities. As such, the decay rate R2∗ will be enhanced
when the local deoxyhemoglobin concentration is increased.
Assuming that blood pO2 is in equilibrium with tissue pO2,
R2∗ values allows to qualitatively compare tissue oxygenation
between different voxel of the same subject and between
subjects: low R2∗ values indicates high tissue oxygenation, and
vice versa (Prasad, 2006). BOLD-MRI has been validated in
animal studies, showing that R2∗ correlates negatively with
directly measured pO2 (Pedersen et al., 2005). However, several
points merit attention in the interpretation of R2∗ values.
First, factors that affect the oxygen dissociation curve (which
describes the relationship between de(oxy)Hb and pO2) such
as blood pH, body temperature, and hematocrite alter the
equilibrium described above, and should be taken into account
when performing BOLD-MRI (Neugarten, 2012). Second, the
BOLD-signal is sensitive to an acute water load (Prasad and
Epstein, 1999). This sensitivity is partly explained by the water-
induced reduction in oxygen-consuming tubular transport, but
an increase in tubular volume after water intake will also
reduce the local deoxyhemoglobin volume fraction and thus
further decrease R2∗. Standardization of water intake is therefore
warranted. Because tubular sodium reabsorption is amajor driver
of oxygen consumption, short-term alterations in dietary sodium
intake influence significantly medullary R2∗ values, and urinary
sodium excretion (as a proxy of sodium intake) should therefore
be measured whenever possible (Pruijm et al., 2010).
While the acquisition of BOLD-MRI is performed in many
centers worldwide, no general consensus exists on how to analyze
the BOLD-images, andmanymethods are in use (see Figure 1 for
a few examples). In the oldest and most frequently used method,
the ROI technique, small circles each containing a collection of
voxels -called regions of interest (ROI’s)- are placed manually in
the cortex and in the medulla of each slice (Figure 1, left image).
This allows the calculation of the average cortical and medullary
R2∗ values, per kidney or for both kidneys together (Simon-Zoula
et al., 2006). Placement of ROIs is easy in kidneys with preserved
renal function, but difficult in patients with advanced CKD due to
the lack of cortico-medullary differentiation in the latter (e.g., the
human eye is no longer capable of differentiating the cortex from
the medulla purely based on radiological contrast differences).
A second, recent method called the TLCO (12 layers concentric
objects) technique is a semi-automatic procedure that divides the
kidney in 12 layers of equal thickness. The mean R2∗ values of
all layers can be plotted as a curve (the R2∗ radial profile) with
a certain slope (Figure 1, middle image). The steepness of the
slope is associated with the degree of CKD: the higher the eGFR,
the steeper the slope (Milani et al., 2016). The R2∗ profile has a
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FIGURE 1 | Three currently used techniques to analyze BOLD-MRI. (Left) Classical ROI-based technique, with placement of circle-shaped regions of interest
(ROIs) in the renal cortex (yellow) and medulla (red); (Middle) Twelve-Layer Concentric Objects (TLCO) technique, which divides the renal parenchyma in 12 layers of
equal thickness; (Right) Fractional hypoxia technique, which counts the percentage of voxels with an R2* value >30 sec−1.
low inter-observer variability and can visualize layer by layer the
effect of external stimuli, making it an interesting tool to study
the effects of drugs, as recently demonstrated (Vakilzadeh et al.,
2015).
Since the BOLD-signal is influenced by many factors, of
which some are scanner related, absolute R2∗ values are not
comparable across sites. The steepness of the R2∗ slopes less
of the R2∗ values, but merely of their intra-compartmental
distribution. This observable may therefore be more suitable for
comparisons across centers, which would be a huge advantage
for eventual future integration in clinical practice. Another way
to overcome this hurdle is to perform a dynamic test (such as the
administration of IV furosemide or 100% oxygen breathing), and
to assess the percentage change in R2∗.
In a third method called the fractional tissue hypoxia-
technique, the whole renal parenchyma is selected, and the
percentage of R2∗ values above a certain threshold (usually
30 s−1 or >2.5 standard deviations of the average R2∗ value) is
reported (Saad et al., 2013). This technique provides a variable—
the percentage of hypoxic tissue- that can be easily interpreted
by clinicians, but it does not differentiate between cortex and
medulla (Figure 1, right image).
Taken together, each technique has his advantages and
disadvantages. The most promising and reproducible technique
for CKD patients is at the moment, to our opinion, the TLCO
method; international efforts are ongoing and necessary to
standardize analysis methods in the years to come.
BOLD-MRI IN CKD
Surprisingly, BOLD-MRI studies have not uniformly
demonstrated that renal tissue oxygenation is reduced in
CKD patients as compared with controls. Some studies reported
higher R2∗ values suggesting lower renal oxygenation at lower
eGFR, whereas other studies did not find any correlation
between CKD status and R2∗ (Table 1). Unfortunately, many of
the “early” studies lacked information on drug-or sodium intake,
did not standardize water intake, or did not differentiate between
the underlying causes of CKD. However, even well-designed
studies failed to show differences in R2∗ between persons with
and without CKD (Khatir et al., 2015). It has become clear
that the analysis technique has a large impact on the results.
Our research group has recently demonstrated that the ROI
technique is highly observer-dependent in advanced CKD, and
should therefore not be used in these patients (Piskunowicz et al.,
2015). The importance of the used analysis technique is further
illustrated by the fact that our research group did not find any
differences in R2∗ with the ROI technique, whereas the use of the
TLCO technique in the same patient cohort showed significant
differences in R2∗ between the cortical layers of CKD patients
and controls (Milani et al., 2016).
As can be appreciated in Table 1, recent BOLD-MRI studies
have actually demonstrated that CKD patients have higher R2∗
values (corresponding to lower renal tissue oxygenation) as
compared to controls, thus confirming the findings of animal
studies. Differences in R2∗ were mainly confined to the cortex,
which is somewhat surprising, since the cortex has higher pO2
values than themedulla (50 vs. 10–20mmHg), receives 90% of the
renal blood flow, and has relatively lower oxygen consumption
than the medulla (Aukland and Krog, 1960; Heyman et al., 2008).
In theory, the cortex should therefore be better protected against
hypoxia. Whether this is explained by glomerular hyperfiltration
in residual glomeruli, altered diffusive shunting pathways or
reduced metabolic efficiency of solute transport in tubular cells
is actually unclear. Of note, although the mean R2∗ is higher
in CKD patients, differences are small, and according to some
authors mainly driven by a minority of CKD patients with high
R2∗ values (Prasad et al., 2015). This finding illustrates that renal
tissue oxygenation is rather tightly controlled in the majority
of individuals. In this respect, some have stated that interstitial
fibrosis- the consequence of hypoxia and one of the hallmarks of
advanced kidney disease- might be a way to maintain to a certain
degree renal oxygenation, by decreasing local oxygen-consuming
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TABLE 1 | Overview of the studies that have used BOLD-MRI to assess renal tissue oxygenation in CKD patients as compared with controls.
Author N Design Field strength (Tesla) Analysis method R2* cortex R2* medulla Remark
Inoue 2011 119 CKD-control 1.5 ROI No difference Not available Only DM
Wang 2011 27 CKD-control 1.5 ROI No difference Lower in CKD Only DM
Michaely 2012 280 Observational 1.5 and 3 ROI No difference No difference
Xin-Long 2012 26 CKD-control 3 ROI Higher in CKD Higher in CKD
Yin 2012 115 CKD-control 3 ROI Higher in CKD Higher in CKD Only DM
Pruijm 2014 195 CKD-control 3 ROI No difference No difference
Vink 2015 75 Hypertensives 1.5 and 3 Fractional and Compartmental No difference Higher at lower eGFR eGFR 75 ± 18 ml/min
Thacker 2015 47 CKD-control 3 Large ROI-entire parenchyma Higher in CKD No difference
Prasad 2015 59 CKD-control 3 ROI Higher in CKD No difference
Khatir 2015 86 CKD-control 1.5 ROI No difference No difference
Milani 2016 207 CKD-control 3 TLCO Higher in CKD Lower in CKD
active transport. Long-term 5/6 nephrectomy models in the rat
have indeed reported maintained pO2 levels in remnant kidneys
(Priyadarshi et al., 2002). In humans, this hypothesis has not been
confirmed so far; one study reported no correlation between R2∗
values and the degree of fibrosis (Ries et al., 2003), another found
higher R2∗ values at increasing degrees of biopsy-proven fibrosis
(Inoue et al., 2011). Finally, it is actually unknown whether CKD
patients with high R2∗ values have more progressive disease than
those with lower R2∗ values, and longitudinal follow-up studies
are therefore eagerly awaited.
BOLD-MRI AND DRUGS
As stated in the introduction, BOLD-MRI can be repeated many
times without side effects, making it an interesting tool to study
the effect of drugs. On this behalf, the loop diuretic furosemide
has been the most investigated. Blocking the Na+-K+-2Cl−
transporter in the thick ascending loop of Henle with an IV
bolus of furosemide leads to an acute decrease in active oxygen-
consuming sodium transport, and increases local pO2 (Liss
et al., 1999). As a proof of concept, acute furosemide-induced
decreases in medullary R2∗ have been reported in both animals
and humans (Brezis et al., 1994; Epstein and Prasad, 2000). Of
interest, the medulla of CKD patients shows smaller decreases in
R2∗ in response to furosemide than controls, and the furosemide-
induced R2∗ change correlates well with the eGFR (Pruijm et al.,
2014). This is explained by some as purely a dose effect due
to the reduced renal function. Indeed, in order to exert its
natriuretic action, furosemide has to be secreted by the proximal
tubular cells, which is less the case at lower eGFR. Others see the
R2∗ response as an indicator of tubular function and transport.
For example, hypertensive individuals show, as CKD patients,
a blunted R2∗ response to furosemide, although their eGFR is
preserved, an observation that possibly refers to altered tubular
sodium handling in hypertensives. Whether the R2∗ response
to furosemide is indeed a marker of tubular function and mass,
and has prognostic potential to predict adverse renal outcome, is
currently unknown.
Few studies have tested other drugs with regard to their
effect on R2∗. One of the earliest studies reported acute
increases in medullary and cortical R2∗ after iodinated contrast
products, which is in line with their well-known vasoconstrictive
and nephrotoxic potential (Hofmann et al., 2006). Inversely,
acute decreases in R2∗ (within 1 h) have been described
after the administration of blockers of the renin-angiotensin
system in small studies that included hypertensive or CKD
patients (Djamali et al., 2007; Siddiqi et al., 2014). This is in
line with the nephroprotective properties of these drugs, that
lower intraglomerular pressure, tubular sodium transport, local
inflammation, and oxidative stress (Tocci and Volpe, 2011). In
contrast, chronic intake of renin-angiotensin system inhibitors
did not alter renal R2∗ values (Pruijm et al., 2013), although a
small decrease in cortical R2∗ values was found in hypertensive
patients after 2 months of aliskiren (Vakilzadeh et al., 2015).
These studies show that acute alterations in R2∗ occur, but they
also illustrate once more that chronic renal tissue oxygenation
is rather tightly controlled. The acute, drug induced- alterations
in R2∗ offer insights in the mechanism of action and possibly
nephroprotective potential of drugs in a preclinical setting.
BOLD-MRI can be combined with other MRI methods such as
arterial spin labeling, capable of measuring localrenal blood flow,
or dynamic contrast enhanced-imaging that can directly measure
glomerular filtration rate (Ebrahimi et al., 2014). Therefore,
functional MRI can provide a wealth of information in the
renal mechanisms of action of drugs, and possibly indicate renal
side effects or benefits long before clinical outcome studies.
Considering animal studies, functionalMRI also has the potential
to reduce animal usage. For these reasons, we expect functional
MRI to play an increasingly important role in drug research.
BOLD-MRI AND RENAL ARTERY
STENOSIS
As any organ, renal tissue oxygenation depends not only of local
oxygen consumption (mainly active tubular sodium-dependent
transport), but also of oxygen delivery (renal blood flow and
hemoglobin level). Renal artery stenosis (RAS) is the classic
example of ischemic nephropathy, and one would expect to find
cortical and medullary hypoxia in this patient group. Animal
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studies have indeed reported acute increases in R2∗ after clipping
of the renal artery (Juillard et al., 2004). However, no hypoxia
could be detected with BOLD-MRI 4 weeks after clipping of the
renal artery (Rognant et al., 2010). As in the remnant kidney
model, the kidneys at the side of the clipped renal artery were
atrophic and non-functional, and this study therefore does not
necessarily reflect the situation as often encountered in the clinic
when RAS kidneys are (slightly) reduced in size, but not atrophic.
In humans, BOLD-MRI has, to the best of our knowledge,
not been used in situations of acute renal artery occlusion. In
chronic RAS, increases in R2∗ have been reported in patients
with severe RAS (>90%), but not in those with less severe RAS
(Gloviczki et al., 2011a). Hence, renal tissue oxygenation seems
to be relatively independent from global renal blood flow. Of
note, kidneys have the particularity that increases in RBF do not
necessarily increase local pO2. Indeed, an increase in RBF leads,
at constant filtration fraction, also to a higher GFR which on its
term will increase the amount of filtered sodium, and thus the
tubular sodium load and oxygen consumption (Hansell et al.,
2013).
Some investigators have used the R2∗ response to furosemide
as a marker of viability of renal tissue (Gloviczki et al., 2011b).
In unilateral RAS, the eGFR does not provide information on
the relative function of each kidney, whereas BOLD-MRI allows
per-kidney analysis. The research group from the Mayo Clinic
has demonstrated that the change in R2∗ after IV furosemide is
smaller in those with severe RAS and reduced renal volume than
in those with moderate RAS, and that non-viable renal tissue
is therefore possibly defined as tissue that does not exhibit any
change in R2∗ after furosemide (Gloviczki et al., 2011a).
CLINICAL APPLICATIONS AND
PERSPECTIVES
Renal Artery Stenosis
Large randomized trials such as the Angioplasty and Stenting
for Renal Artery Lesions trial (ASTRAL) have tempered the
enthusiasm of clinicians to perform renal artery angioplasty ±
stenting in RAS patients (Investigators et al., 2009). Nevertheless,
it is well known that some patients definitely benefit from
angioplasty, and the main question remains how to predict the
outcome of this procedure. The studies outlined above show
that renal oxygenation can be maintained over a wide range of
stenosis, but that above a certain individual threshold, chronic
ischemia occurs, leading to inflammation, and decline of renal
function, and diminished response to furosemide (Gloviczki
et al., 2011a,b). This suggests that patients who will most
likely benefit from angioplasty present chronic ischemia and
a maintained response to furosemide, but this has not been
tested in clinical practice. Hermann et al. recently reported that
fractional hypoxia was higher in the stenotic kidneys of patients
with high-grade RAS than in patients with essential hypertension
(22.1 ± 20 vs. 9.6 ± 7%). Fractional hypoxia diminished (from
22.1 ± 20 to 14.9 ± 18.3%) after renal stenting (Herrmann et al.,
2016). In a similar way, an English research group showed that
those with higher overall R2∗ levels and preserved renal volume
and function had favorable outcomes after revascularization
(Chrysochou et al., 2012). The integration of functional BOLD-
MRI in the workup and decision process of RAS opens new
perspectives, but this needs further validation in clinical studies.
Chronic Kidney Disease
Ideally, BOLD-MRI should identify patients at increased risk
of CKD progression, expecting that those with the lowest renal
oxygenation, or the lowest R2∗ change after furosemide, have
the highest risk of progression. So far, these data are lacking,
hampering the introduction of BOLD-MRI in clinical practice.
Another issue is the fact that BOLD-MRI alone cannot
establish whether a high R2∗ value is the result of low
oxygen delivery (low RBF, extended renal fibrosis), high oxygen
consumption (glomerular hyperfiltration, enhanced tubular
absorption), or both. CKD is characterized by increased fibrosis,
which on the one hand limits oxygen diffusion out of capillaries
into renal cells, yet on the other hand also limits oxygen
consumption. Quantifying fibrosis and regional blood flow,
in combination with BOLD-MRI, could therefore provide
useful information. Apart from T1mapping, so-called diffusion-
weighted MRI (DW-MRI) offers a non-invasive way to quantify
renal fibrosis and microcirculation. DW-MRI collects images
with and without diffusion weighted gradients, and expresses
molecular diffusion as the apparent diffusion coefficient (ADC)
Liss et al., 2013. The total ADC can be separated in a perfusion
fraction (Fp) and perfusion-free diffusion (ADCD), as measures
of local microcirculation and fibrosis. A reduction in ADC has
been shown to correlate with CKD staging and the degree of
fibrosis (Xu et al., 2010; Zhao et al., 2014), and a reduction
in Fp has been demonstrated in renal allografts suffering from
acute rejection (Eisenberger et al., 2010). Whether a combination
of BOLD-MRI and diffusion MRI is capable of predicting
renal function decline is not yet known, and subject of active
research.
CONCLUSION
BOLD-MRI is an exciting technique to assess renal oxygenation
non-invasively in humans. Increased knowledge of factors that
influence the BOLD-signal has lead to better standardization,
and refinements in the analysis technique to highly reproducible
results. BOLD-MRI is a powerful tool to detect the influence
of altered hemodynamics, drugs, or dietary factors on renal
oxygenation. The near future will tell if BOLD-MRI (alone or
in combination with other MRI modalities) allows the selection
of RAS patients who will benefit from revascularization, and/or
early identification of CKD patients at high risk for renal function
decline.
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